References
- Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205 https://doi.org/10.1016/S0016-5085(98)70381-6
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15(1): 79-94 https://doi.org/10.1128/CMR.15.1.79-94.2002
- Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
- Weitzma SA, Gordon LI. Inflammation and cancer: role of phagocyte- generated oxidants in carcinogenesis. Blood 1990; 76: 655- 663
- Stadnichi A, Cloman RW. Experimental models of inflammatory bowel disease. Arch Immunol Ther Exp 2003; 51(3): 149-155
- Grip O, Janciauskiene S, Lindgren S. Macrophages in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2003; 2: 115-160
- Yoshida N, Yoshikawa T, Yamaguchi T, Naito Y, Tanigawa T, Murase H, Kondo M. A novel water-soluble vitamin E derivbative protects against experimental colitis in rats. Antioxid Redox Signal 1999; 1: 555-562 https://doi.org/10.1089/ars.1999.1.4-555
- Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264 https://doi.org/10.1016/0027-5107(94)90245-3
- Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98(3): 694-702 https://doi.org/10.1016/0016-5085(90)90290-H
- Ohkusa T. Production of experimental ulcerative colitis in hamster by dextran sulfate sodium and changes in intestinal microflora. Jpn J Gastroenterol 1985; 82: 1327
- Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107(6): 1643 https://doi.org/10.1016/0016-5085(94)90803-6
- Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1983; 96(3): 795- 803
- Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M. Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rat. Nippon Yakurigaku Zasshi 1996; 108(5): 259-266 https://doi.org/10.1254/fpj.108.259
- Kuhn R, Lohler J, Rennikc D, Rajewsky K, Muller W. Interleukin- 10-deficient-mice develop chronic enterocolitis. Cell 1993; 75: 263-274 https://doi.org/10.1016/0092-8674(93)80068-P
- Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993; 75: 274- 282
- Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel diesease. Gastroenterology 1995; 109: 1344 https://doi.org/10.1016/0016-5085(95)90599-5
- Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein BE, Buchler MW. Characterisation of acute murine dextran sodium sulfate colitis: cytokine proile and does dependency. Digestion 2000; 62: 240-248 https://doi.org/10.1159/000007822
- Kitajima S, Takoma S, Morimoto M. Changes in colonic mucosal permeability mouse colitis induced with dextran sulfate sodium. Exp. Animal 1999; 48: 137-143 https://doi.org/10.1538/expanim.48.137
- Msiewicz JJ, Lennard-hones JE, Connell AM. controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet 1965; 1: 185-188 https://doi.org/10.1016/S0140-6736(02)95624-2
- Boumpas DT, Chrousos GP, Wilder RL. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-1208 https://doi.org/10.7326/0003-4819-119-12-199312150-00007
- Guarner F, Schaafsma GJ. Short communication Probiotics. Int. Jour of Food Microbiol 1998; 39: 237-238 https://doi.org/10.1016/S0168-1605(97)00136-0
- Kandler O, Kunath P. Lactobacillus kefir sp., component of microflora of kefir. Syst. Appl Microbiol 1983; 4: 286-294 https://doi.org/10.1016/S0723-2020(83)80057-5
- Dong Shin Kim, Sang Kyo Park, Kwak Hae Soo, Kil Wang Lee. Isolation, Identification and Characterization of Lactose Nonfermenting Yeast from Kefir Cultures. Korean J food Sci Resour 1994; 14(2): 175-178
- Garrote GL, Abraham AG, De Antoin GL. Inhibitory power of kefir: the role of organic acids. J. Food Prot 2000; 63: 364-369 https://doi.org/10.4315/0362-028X-63.3.364
- Shiomi MK, Sasaki M, Murofushi K. Aibara. Antirumor activity in mice of orally administered polysaccharide from kefir grain. Jap J Medical Science and Biology 1982; 35: 75-80 https://doi.org/10.7883/yoken1952.35.75
- Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN- 76A rodent diet. J Nutr 1993; 123(11): 1939-1951 https://doi.org/10.1093/jn/123.11.1939
- Bradley PR, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of Neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78(3): 206-209 https://doi.org/10.1111/1523-1747.ep12506462
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358 https://doi.org/10.1016/0003-2697(79)90738-3
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254 https://doi.org/10.1016/0003-2697(76)90527-3
- Giles KW, Myers A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 93
- Burton KA. Study of conditious and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1965; 62: 315
- Park SY, Seo DY, Suh KS, Ly SY. Oxidative stress of mouse fed with ɣ-Irradiated soybean diet. Korean J Nutr 2007; 40(2): 138- 146
- Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209 https://doi.org/10.1016/S0016-5085(03)00171-9
- Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics 1999; 13: 1103-1108 https://doi.org/10.1046/j.1365-2036.1999.00560.x
- Ichikawa H, Huroiwa T, Inagaki A, Shineha R, Nishihira T, Satomi S, Sakata T. Probiotic bacteria stimulate gut epithelial cell proliferation in rat. Digestive Disease and Sciences 1999; 44: 2119-2123 https://doi.org/10.1023/A:1026647024077
- Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. Journal of Biological Chemistry 2002; 277: 50959-50965 https://doi.org/10.1074/jbc.M207050200
- Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003; 52: 370-6 https://doi.org/10.1136/gut.52.3.370
- Fuller R, Gibson GR. Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 1977; 222: 28-31
- Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519 https://doi.org/10.1016/S0140-6736(03)12489-0
- Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 101(2): 229-238 https://doi.org/10.1016/S0002-8223(01)00060-8
- Furrie E. Probiotics and allergy. 2005; 64(4): 465-469
- Bibiloni R, Fedorak RN, Tannock GW, Madsen, KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 2005; 100: 1539-1546 https://doi.org/10.1111/j.1572-0241.2005.41794.x
- Fujiwara M, Kaneko T, Iwana H, Taketomo N, Tsunoo H, Kanno J, Ohkusa T, Okayasu I. Inhibitory effects of Bifidobacterium longum on experimental ulceratice colitis induced in mice by synthetic dextran sulfate sodium. Digestion 2003; 67: 90-95 https://doi.org/10.1159/000069704
- Setoyama H, Imakka A, Ishikawa H, Umesaki Y. Prevention of gut inflammation by bifidobacterium in dextran sulfate treated gnotobiotic mice associated with bacteroids strains iisolated from ulcerative colitis patients. Microbes and Infection 2003; 5: 115- 122 https://doi.org/10.1016/S1286-4579(02)00080-1
- Osman N, Adawi D, Ahrne S, Jeppsson B, Molin G. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 2004; 49: 320-327 https://doi.org/10.1023/B:DDAS.0000017459.59088.43
- Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006; 4(2): 261-275 https://doi.org/10.1586/14787210.4.2.261
- Oz HS, McClain CJ, Nagasawa H, Mukunda R, Chen TS. Antioxidants as novel therapy in a murine model of colitis. Journal of Nutritional biochemistry 2005; 16: 297-304 https://doi.org/10.1016/j.jnutbio.2004.09.007
- Fabia R, Willen R, Ar'Rajab A, Andersson R, Ahren B, Bengmark S. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24: 211-225 https://doi.org/10.1159/000129209
- Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Morin G, Jeppsson B. The effects of Lactoba-cillus strains and Oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996; 111(2): 334-344 https://doi.org/10.1053/gast.1996.v111.pm8690198
- Souza MM, Aguilar-Nascimento JE, Gomes-da-Silva MH, Carlos Junior R. Effects of budesonide and probiotics enemas on the colonic mucosa of rats with experimental colitis. Acta Cir Bras 2007; 22(1): 34-38
- Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Digestive Diseases and Sciences 1988; 33: 6S-15S https://doi.org/10.1007/BF01538126
- Lu J, Wang A, Ansari S, Hershberg RM, McKay DM. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 2003; 125(6): 1785-1795 https://doi.org/10.1053/j.gastro.2003.09.020
- Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Journal of Gastroenterology and Hepatology 2002; 17(13): 1291-1298 https://doi.org/10.1046/j.1440-1746.2002.02868.x
- Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B. Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Znsuperoxide dismutase and plasma malondialdehyde levels in experimental colitis. Mediators of inlfammation 2005; 6: 390-394
- Williams JG, Hughes LE, Hallett MB. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990; 31(2): 187-193 https://doi.org/10.1136/gut.31.2.187
- Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. European Journal of pharmacology 2001; 412: 91-99 https://doi.org/10.1016/S0014-2999(00)00926-2
- Liu LN, Mei QB, Liu L, Zhang F, Liu ZG, Wang ZP, Wang RT. Protective effcts of Rheum tanguticum polysaccharide against hydrogen peroxide-induced intestinal epithelial cell injury. World J Gastroenterol 2005; 11(10): 1503-1507 https://doi.org/10.3748/wjg.v11.i10.1503
- Mahgoub AA, El-Medany AA, Hager HH, Mustafa AA, El- Sabah DM. Evaluating the prophylactic potential of zafirlukast against the toxic effects of acetic acid on the rat colon. Toxicol Lett 2003; 145(1): 79-87 https://doi.org/10.1016/S0378-4274(03)00269-8
- Mabley JG, Pacher P, Liaudet L, Soriano FG, Hasko G, Marton A, Szabo C, Salzman AL. Inosine reduces inflammation and improves survival in a murine model of colitis. Am J physiol Gastrointest Liver Physiol 2003; 284(1):138-144 https://doi.org/10.1152/ajpgi.00060.2002
- Cuzzocrea S, Mazzon E, Serraino I, eV, nova ML, oA, Caputi. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001; 30(1): 1-12 https://doi.org/10.1034/j.1600-079X.2001.300101.x
- Embvani E, Tardieu D, Jaeg JP, Corpet DE, Petit C. Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2'-deoxyguanosine, in rats colonic mucosa. Toxicology Letters 1998; 95(1): 190
- Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, Mcclung J, Shebini K, Moore F, O'brien M, Becker JM. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate- induced colitis in rats. Am J Physiol 2000; 279: 1298-1306
- Girgin F, Karaoglu O, Erkus M, Tuzun S, Ozutemiz O, Dincer C, Batur Y, Tanyalcin T. Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis. J Toxicol Environ Health A 2000; 59(8): 641-652 https://doi.org/10.1080/009841000156637
- Girgin F, Karaoglu O, Tuzun S, Erkus M, Ozutemiz O, Dincer C, Batur Y, Tanyalcin T. Effects of trimetazindine in ethanol and acetic acid induced colitis: oxidant/anti-oxidant status. Colorectal Disease 1999; 1: 338-346 https://doi.org/10.1046/j.1463-1318.1999.00078.x
- Guven A, Gulemez M. The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachlorideinduced mice tissues. J Vet Med 2003; 50: 412-416 https://doi.org/10.1046/j.1439-0450.2003.00693.x
- Tsutomu N, Junko N, Kiichirou T, Yoshinori K, Sun-yup S, Kenichi K, Sennosuke T, Koichiro T, David WB, Sanetaka S. Suppression of UVC-induced cell damage and enhancement of DNA repair by the fermented milk, Kefir. Cytotechnology 2002; 40: 125-137 https://doi.org/10.1023/A:1023984304610
- Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. International Journal of Colorectal Disease 2006; 21: 737-746 https://doi.org/10.1007/s00384-005-0773-y